Tsinghua’s Venture Arm Leads $18M Round In Cancer Diagnosis Start-Up

This Data Is Locked!

This area is available only to Subscribers.

Beijing-based THG Ventures, a venture capital arm of Tsinghua Holdings, has led a RMB128 million (US$18 million) series B round in Genecast, a Beijing-based cancer... [DATA LOCKED]

UNLOCK DATA

Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals

Access Thousands of Data Points to Monitor Chinese Private Equity Deal Movement and Relationships

Already Have an Account?